ID   NCC-SFT1-C1
AC   CVCL_E6MC
RX   PubMed=39904835;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~69 hours (PubMed=39904835).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 6 fused to STAT6 exon 16 (PubMed=39904835).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Left buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=39904835
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D21S11: 30,31
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7634; Solitary fibrous tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=39904835; DOI=10.1007/s13577-025-01175-1;
RA   Iwata S., Noguchi R., Osaki J., Adachi Y., Shiota Y., Kobayashi E.,
RA   Takemori T., Nishino S., Yoshida A., Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-SFT1-C1: a novel
RT   patient-derived cell line of solitary fibrous tumor.";
RL   Hum. Cell 38:49.1-49.8(2025).
//